
It has not been ascertained that treatment of glioblastoma multiforme of the brain (GMB) favorably alters the prognosis in patients with poor pretreatment performance status (PPS). We report on 52 patients with GMB and PPS. The mean survival of 43 treated persons was 19 +/- 12 months (95% confidence interval) and of nine untreated individuals, 2 +/- 1 months (p > 0.50); the corresponding survival rates at 1 year were 39 +/- 16% and 0% (p > 0.05) and at 2 years, 15 +/- 12% and 0% (p > 0.40). We recommend active treatment of patients with GMB even when they present with poor functional status.
Male, Brain Neoplasms, Middle Aged, Combined Modality Therapy, Survival Rate, Treatment Outcome, Humans, Female, Karnofsky Performance Status, Neoplasm Recurrence, Local, Glioblastoma, Tomography, X-Ray Computed, Aged, Follow-Up Studies, Retrospective Studies
Male, Brain Neoplasms, Middle Aged, Combined Modality Therapy, Survival Rate, Treatment Outcome, Humans, Female, Karnofsky Performance Status, Neoplasm Recurrence, Local, Glioblastoma, Tomography, X-Ray Computed, Aged, Follow-Up Studies, Retrospective Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
